Global Canine Atopic Dermatitis Market by Mode Of Administration (Oral, Topical), by Distribution Channel (Retail, E-commerce) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global canine atopic dermatology market was valued at USD 911.6million in 2019. It is expected to grow 9.0% over the forecast period. This market is driven by the rising incidence of atopic dermatology in dogs that are allergic to allergens and air pollution. Atopic dermatitis is characterized by itching, scratching, foul odor, loss hair, and scaly skin. Labrador, Golden Retriever, Labrador and Pug are the most common breeds that are susceptible to canine atopic dermatologitis. The market is expected to grow rapidly due to rapid industrialization in both developing and advanced countries.

According to an American College of Veterinary Dermatology report, 10% to 15% of canine atopic dermatitis cases were reported in 2017. Although the exact cause of this condition is unknown, genetic abnormalities have been suggested to be one reason. The risk of developing canine atopic dermatitis (canine dermatitis) in golden retrievers in the United Kingdom was approximately 50% according to an American Journal Of Veterinary Research study. This is due to geographical variation which will increase the revenue over the next few years.

One of the main factors behind the increasing demand for this market is the growing number of veterinary professionals. The American Veterinary Medical Association reported that 113,394 veterinary professionals were in the United States in 2018, compared with 110,531 in 2017. The market is also growing due to the increasing number of veterinary clinics and hospitals.

Market growth will also be aided by increased R&D investment from key industry players, product launches and a strong drug pipeline. Kindred Biosciences, Inc., for example, has four monoclonal anti-canine atopic dermatitis monoclonal antibodies in its pipeline. This is expected to be launched in the next five years. Cytopoint was a monoclonal antibody that Zoetis introduced in 2016. It became a hugely successful drug in 2018.

In the next few years, the market will see a positive effect due to rising demand for dog insurance and growing concern from pet owners. Market growth is also being supported by strict regulations from the Food and Drug Administration (FDA), and other regulatory agencies to limit the use of human drugs in animals.

Product Insights

The market for canine atopic dermatology treatment is divided by product into antihistamines and immunosuppressants, glucocorticoids, MAbs, and other. Due to their increased use and lower cost, glucocorticoids dominated 2019's market in terms revenue. Topical and oral glucocorticoids were the most effective treatment options for canine atopic dermatology. For acute flares, oral prednisone and prednisolone as well as methylprednisolone tend to be preferred. Side effects are much less than with other forms of prednisone.

Over the forecast period, Monoclonal Antibodies segment (MAbs), is expected to experience lucrative growth. This therapy is relatively new, but has been proven to be extremely effective. Zoetis' first MAb was launched in 2016. It is given to patients every four to eight week and claims to reduce itching. More MAbs are currently in clinical trials, and they are expected to deliver positive results over the next few years.

Mode of Administration Insights

The market for canine atopic dermatology is divided into three segments based on the mode of administration: topical, injectable, and oral. Due to its lower price, the oral segment accounted for the highest revenue share in 2019. It is also more convenient than topical and injectable options. Dog owners can also administer the drug themselves, which further fuels its demand.

Due to its effectiveness and potency, the injectable market is expected to grow in value over the next few years. Injectables have a rapid onset of action, which will drive demand. For better results, veterinarians recommend a combination oral-injectable therapy. The availability of a large product pipeline will fuel the growth of the injectable market.

Distribution Channel Insights

The market for canine atopic dermatology treatment is divided by the distribution channel into veterinary clinics/clinics and retail. Due to the increased availability of products, the retail segment dominated this market in 2019. Retail pharmacy chains are a key contributor to the market share. The adoption of digitalized systems by retail pharmacies in order to reduce the risk of prescription errors is expected to drive revenue growth in the next years. Further, the market is booming because veterinarians are now able to use general pharmacies to fill their prescriptions for drugs that are not available at vet pharmacies.

The e-commerce market is expected to grow in popularity over the next few years. It is easy to shop from a variety of products on websites that provide detailed product descriptions. This is driving the market. This segment is also expected to see increased revenue due to discounts offered by different websites and the increasing preference of consumers to purchase products online.

Regional Insights

In 2019, North America was the dominant regional market and it is expected to continue this trend in the future. This is due to an increase in canine atopic dermatology in pets, new product launches and growing concern from pet owners. Market growth is also being boosted by the increasing pet ownership. The growth is expected to be driven by the high level of investment made by major players in the development and production of new drugs.

Latin America accounted for a significant portion of the market, due to the large number of pet dogs living in this region. Brazil and Argentina rank among the top 10 countries with the most pets worldwide. The Asia Pacific region will experience lucrative growth during the forecast period. The future growth prospects are further enhanced by the possibility of greater adoption of companion animals due to the rising disposable income. The market is expected to see high growth potential over the forecast period due to the continuous improvement of its healthcare infrastructure.

Canine Atopic Dermatitis Market Insights

The market is highly concentrated in nature. Zoetis accounted for more than half of the 2018 revenue share. In 2018, the two main drugs for canine atopic dermatology, Cytopoint and Apoquel, generated significant revenue. These drugs saw a 20% increase in 2018 and are expected to continue to grow in the future.

Elanco and Virbac are also key players in this market. The market will be supported by a large product pipeline from new industry players like Kindred Biosciences and AB Science in the next few years. To maintain their market share, players are adopting strategies such as mergers and acquisitions, regional expansion, launch of new products, and other strategies. To increase regional revenue share, Zoetis launched Apoquel in China in February 2019.

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2016 to 2027. Grand View Research has divided the global market for canine atopic dermatology on the basis: mode of administration, product, distribution channel, region.

• Product Outlook (Revenue USD Million, 2016-2027)

  • Glucocorticoids

  • Antihistamines

  • Immunosuppressants

  • MAbs

  • Other

• Mode of Administration Outlook (Revenue USD Million, 2016-2027)

  • Topical

  • Oral

  • Injectable

• Distribution Channel Outlook (Revenue USD Million, 2016-2027)

  • Veterinary Clinics/Clinics

  • Retail

  • E-commerce

• Regional Outlook (Revenue USD Million, 2016-2027)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

Up Market Research published a new report titled “Canine Atopic Dermatitis Market research report which is segmented by Mode Of Administration (Oral, Topical), by Distribution Channel (Retail, E-commerce), By Players/Companies Zoetis launched its blockbuster drug Apoquel in China to gain regional revenue share, in February 2019, Elanco, Virbac, Toray Industries Extensive product pipeline by some new industry players such as Kindred Biosciences, acquisitions, regional expansion, launch of new products are being adopted by the players to maintain their share For instance, AB Science is expected to bolster the market in the coming years Strategies such as mergers”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Canine Atopic Dermatitis Market Report Segments:

The market is segmented by Mode Of Administration (Oral, Topical), by Distribution Channel (Retail, E-commerce).

Canine Atopic Dermatitis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Canine Atopic Dermatitis Market

Overview of the regional outlook of the Canine Atopic Dermatitis Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Canine Atopic Dermatitis Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Canine Atopic Dermatitis Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Oral

                2. Topical

                1. Retail

                2. E-commerce

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Canine Atopic Dermatitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Canine Atopic Dermatitis Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.